346 related articles for article (PubMed ID: 17635820)
1. Renal osteodystrophy, phosphate homeostasis, and vascular calcification.
Hruska KA; Saab G; Mathew S; Lund R
Semin Dial; 2007; 20(4):309-15. PubMed ID: 17635820
[TBL] [Abstract][Full Text] [Related]
2. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
Mathew S; Davies M; Lund R; Saab G; Hruska KA
Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
[TBL] [Abstract][Full Text] [Related]
3. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
Stubbs J; Liu S; Quarles LD
Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
[TBL] [Abstract][Full Text] [Related]
4. Mineral and bone disorders in patients on dialysis: physiology and clinical consequences.
McCarley PB; Arjomand M
Nephrol Nurs J; 2008; 35(1):59-64. PubMed ID: 18372764
[TBL] [Abstract][Full Text] [Related]
5. [Renal osteodystrophy: role of vitamin D and parathyroid hormone].
Drüeke T; Ulmann A
Nouv Presse Med; 1979 May; 8(23):1901-3. PubMed ID: 223122
[No Abstract] [Full Text] [Related]
6. Rheumatic manifestations of renal disease.
Bardin T; Richette P
Curr Opin Rheumatol; 2009 Jan; 21(1):55-61. PubMed ID: 19077720
[TBL] [Abstract][Full Text] [Related]
7. Vascular calcification and renal osteodystrophy relationship in chronic kidney disease.
Moe SM
Eur J Clin Invest; 2006 Aug; 36 Suppl 2():51-62. PubMed ID: 16884398
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure.
Cozzolino M; Gallieni M; Brancaccio D; Arcidiacono T; Bianchi G; Vezzoli G
J Nephrol; 2006; 19(5):566-77. PubMed ID: 17136683
[TBL] [Abstract][Full Text] [Related]
9. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
Mehrotra R
J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
Román-García P; Carrillo-López N; Cannata-Andía JB
J Ren Care; 2009 Mar; 35 Suppl 1():34-8. PubMed ID: 19222729
[TBL] [Abstract][Full Text] [Related]
11. [Vitamin D metabolism and chronic kidney disease].
Honda H; Sanada D; Akizawa T
Clin Calcium; 2006 Jul; 16(7):1143-46. PubMed ID: 16816474
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD).
Hruska KA; Choi ET; Memon I; Davis TK; Mathew S
Pediatr Nephrol; 2010 Apr; 25(4):769-78. PubMed ID: 19898875
[TBL] [Abstract][Full Text] [Related]
13. The association of chronic kidney disease-mineral bone disorder and cardiovascular risk.
Eddington H; Kalra PA
J Ren Care; 2010 May; 36 Suppl 1():61-7. PubMed ID: 20586901
[TBL] [Abstract][Full Text] [Related]
14. Renal osteodystrophy: past and future.
Slatopolsky E; Lopez-Hilker S; Dusso A; Brown A; Delmez J; Martin K
Contrib Nephrol; 1990; 78():38-45; discussion 45-6. PubMed ID: 2225842
[No Abstract] [Full Text] [Related]
15. [Role of vitamin D in the pathogenesis of renal osteodystrophy].
Nakanishi S; Fukagawa M
Clin Calcium; 2004 Sep; 14(9):15-20. PubMed ID: 15577104
[TBL] [Abstract][Full Text] [Related]
16. Secondary hyperparathyroidism in chronic kidney disease: clinical consequences and challenges.
Michael M; Garcia D
Nephrol Nurs J; 2004; 31(2):185-94; quiz 195-6. PubMed ID: 15114799
[TBL] [Abstract][Full Text] [Related]
17. How important is phosphate in the pathogenesis of renal osteodystrophy?
Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S
Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572
[No Abstract] [Full Text] [Related]
18. Secondary hyperparathyroidism in chronic renal failure.
Wills MR; Savory J
Ann Clin Lab Sci; 1981; 11(3):252-61. PubMed ID: 6264838
[TBL] [Abstract][Full Text] [Related]
19. Soft bones and hard arteries-can we reverse the trend in CKD?
Tomlinson J; Cunningham J
J Ren Care; 2009 Mar; 35 Suppl 1():28-33. PubMed ID: 19222728
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management.
Block GA; Port FK
Am J Kidney Dis; 2000 Jun; 35(6):1226-37. PubMed ID: 10845841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
